The number of claims for the extra fee for hypofractionated radiotherapy for breast cancer showed an increasing trend throughout the 9-year period studied, with an average annual increase rate of 24.0%, including during the COVID-19 pandemic.
← all excerpts
Utilization of radiotherapy and hypofractionated radiotherapy in Japan: long-term trends and the influence of COVID-19 pandemic.
1
—
—